XML 115 R82.htm IDEA: XBRL DOCUMENT v3.22.4
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]      
Net loss attributable to Adaptive Biotechnologies Corporation $ (200,191) $ (207,279) $ (146,227)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 142,515,917 140,354,915 131,216,468
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (1.40) $ (1.48) $ (1.11)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 142,515,917 140,354,915 131,216,468
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (1.40) $ (1.48) $ (1.11)